Sign in to confirm you’re not a bot
This helps protect our community. Learn more
DripAssist Infusion Rate Monitor Validation Results from Kenyatta National Hospital Clinical Study
1Likes
94Views
2021Mar 18
This video is a dissemination webinar that explains the Safe Access to Maternal Medication (SAMM) study that was conducted at Kenyatta National Hospital in Nairobi. A pre-post study, funded by the Saving Lives at Birth grant program (USAID, BMGF, KOICA, GCC), the SAMM study investigated whether usage of the DripAssist Infusion Rate Monitor would impact IV infusion accuracy and side effects of commonly used medications in a maternity ward: oxytocin and magnesium sulfate.

Follow along using the transcript.

ShiftLabs

61 subscribers